AKT1 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human AKT1. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human AKT1. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 32 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, spliceai, string_interaction, transcript, ufeature, uniprot
Generated: 2026-03-26 — For the latest data, query BioBTree directly via MCP or API.
View API calls (42)
AKT1

Section 1: Gene Identifiers

DatabaseIdentifierDescription
HGNCHGNC:391Approved symbol: AKT1
Ensembl GeneENSG00000142208Human gene ID
NCBI Entrez Gene207Gene ID
OMIM164730Gene/locus MIM number
PharmGKB GenePA24684VIP gene (Very Important Pharmacogene)
Genomic Location
AttributeValue
Chromosome14
Cytogenetic Location14q32.33
Start Position (GRCh38)104,769,348
End Position (GRCh38)104,799,934
StrandMinus (-)
Genomic AccessionNC_000014.9
Gene Aliases
  • AKT, PKB, PRKBA, RAC, RAC-alpha, RAC-PK-alpha, PKB-ALPHA Gene Classification

  • Locus Type: Gene with protein product

  • Locus Group: Protein-coding gene

  • Gene Groups: Pleckstrin homology domain containing, AKT kinase family


Section 2: Transcript Identifiers Ensembl Transcripts Total Transcript Count: 90

Transcript IDBiotypeStartEndNotes
ENST00000349310protein_coding104,769,349104,795,751Principal isoform
ENST00000402615protein_coding104,769,352104,794,528
ENST00000407796protein_coding104,769,349104,795,748
ENST00000649815protein_coding104,769,349104,795,748
ENST00000553797protein_coding104,769,396104,795,044
ENST00000554192protein_coding104,769,972104,795,748
ENST00000554581protein_coding104,769,349104,794,124
ENST00000554848protein_coding104,770,341104,794,191
ENST00000555458protein_coding104,769,392104,795,748
ENST00000555528protein_coding104,769,371104,793,700
ENST00000544168protein_coding_CDS_not_defined104,770,155104,777,678
ENST00000553506retained_intron104,769,352104,774,680
ENST00000554585nonsense_mediated_decay104,770,193104,795,748
............+77 additional transcripts
Transcript Biotype Summary:
  • Protein coding: 72
  • Retained intron: 9
  • Nonsense mediated decay: 1
  • Protein coding CDS not defined: 2
  • Other: 6 RefSeq Transcripts (Human, Chromosome 14) Total Human mRNA Count: 7 reviewed + predicted
AccessionTypeStatusMANE Select
NM_001382430mRNAREVIEWEDYES (Canonical)
NM_005163mRNAREVIEWEDNo
NM_001014431mRNAREVIEWEDNo
NM_001014432mRNAREVIEWEDNo
NM_001382431mRNAREVIEWEDNo
NM_001382432mRNAREVIEWEDNo
NM_001382433mRNAREVIEWEDNo
CCDS Identifiers
CCDS ID
CCDS9994
Exons for Canonical Transcript (ENST00000349310) Total Exon Count: 15
Exon IDStartEndStrand
ENSE00002508994104,795,484104,795,751-
ENSE00001184402104,793,127104,793,210-
ENSE00001394660104,792,598104,792,722-
ENSE00003642995104,780,088104,780,216-
ENSE00003473235104,776,659104,776,770-
ENSE00003566907104,775,652104,775,799-
ENSE00003628636104,775,076104,775,207-
ENSE00003557545104,774,938104,775,003-
ENSE00001614411104,773,912104,773,980-
ENSE00001296816104,773,455104,773,580-
ENSE00003724028104,773,251104,773,379-
ENSE00003619354104,772,878104,773,092-
ENSE00003561499104,772,365104,772,452-
ENSE00003684409104,770,745104,770,847-
ENSE00002485852104,769,349104,770,420-

Section 3: Protein Identifiers UniProt Accessions Total Entries: 8

AccessionStatusName
P31749Reviewed (Swiss-Prot) - CANONICALRAC-alpha serine/threonine-protein kinase
A0A087WY56Unreviewed (TrEMBL)
A0A804HJM6Unreviewed (TrEMBL)
A0AAQ5BHJ3Unreviewed (TrEMBL)
A0AAQ5BHK3Unreviewed (TrEMBL)
B0LPE5Unreviewed (TrEMBL)
G3V2I6Unreviewed (TrEMBL)
G3V3X1Unreviewed (TrEMBL)
Canonical Protein Properties (P31749)
PropertyValue
Length480 amino acids
Mass55,686 Da
Alternative NamesProtein kinase B, PKB alpha, Proto-oncogene c-Akt, RAC-PK-alpha
RefSeq Proteins (Human)
AccessionStatusMANE Select
NP_001369359REVIEWEDYES
NP_005154REVIEWEDNo
NP_001014431REVIEWEDNo
NP_001014432REVIEWEDNo
NP_001369360REVIEWEDNo
NP_001369361REVIEWEDNo
NP_001369362REVIEWEDNo
Protein Domains and Families (InterPro) Total Domain/Family Count: 10
InterPro IDNameType
IPR001849PH_domainDomain
IPR000719Prot_kinase_domDomain
IPR000961AGC-kinase_CDomain
IPR017892Pkinase_CDomain
IPR034676Akt1Domain
IPR039026PH_PKBDomain
IPR008271Ser/Thr_kinase_ASActive_site
IPR017441Protein_kinase_ATP_BSBinding_site
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR011993PH-like_dom_sfHomologous_superfamily
Key Protein Features
Feature TypePositionDescription
PH domain5-108Pleckstrin homology domain
Kinase domain150-408Serine/threonine kinase catalytic domain
AGC-kinase C409-480C-terminal regulatory domain
PhosphoserineS124Phosphorylation site
PhosphothreonineT308Activation loop phosphorylation by PDPK1
PhosphoserineS473Hydrophobic motif phosphorylation by mTORC2
Disulfide bondC60-C77
N6-acetyllysineK14, K20Post-translational modification
O-GlcNAcS126, S129, T305, T312Glycosylation sites

Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB Structure Count: 42

PDB IDMethodResolution (Å)Title
1UNQX-ray0.98PH domain with Ins(1,3,4,5)-tetrakisphosphate
1UNRX-ray1.25PH domain with sulfate
1H10X-ray1.40PH domain with Ins(1,3,4,5)-tetrakisphosphate
7MYXX-ray1.39PH domain R86A mutant
4GV1X-ray1.49PKB alpha with AZD5363 inhibitor
1UNPX-ray1.65PH domain apo structure
7NH5X-ray1.90Covalent-allosteric inhibitor 6
8UW9X-ray1.90AKT1(E17K) with compound 4
2UVMX-ray1.94PH domain with benzene tetrakisphosphate
2UZRX-ray1.94E17K cancer mutation PH domain
8UW7X-ray1.97AKT1(WT) with compound 3
3CQWX-ray2.00Kinase with substrate peptide/inhibitor
4EKLX-ray2.00Akt1 with GDC0068
3MVHX-ray2.01Akt1-inhibitor complex
7APJX-ray2.05Autoinhibited Akt1 structure
8UVYX-ray2.11AKT1(E17K) with compound 3
6NPZX-ray2.12Kinase domain with bisubstrate
6CCYX-ray2.18Selective inhibitor complex
4EJNX-ray2.19Autoinhibited form with inhibitor
3CQUX-ray2.20Kinase with substrate peptide/inhibitor
8UW2X-ray2.20AKT1(E17K) with compound 3 (zinc-free)
3QKMX-ray2.20Spirocyclic sulfonamide inhibitors
6HHGX-ray2.30Covalent-allosteric inhibitor 27
6HHJX-ray2.30Covalent-allosteric inhibitor 24b
6S9WX-ray2.30Covalent-allosteric inhibitor 16a
7NH4X-ray2.30Covalent-allosteric inhibitor 3
3QKKX-ray2.30Spirochromane inhibitors
6BUUX-ray2.40Kinase domain with bisubstrate
2UZSX-ray2.46E17K cancer mutation
3MV5X-ray2.47Akt1-inhibitor complex
3OW4X-ray2.60Dihydrofuropyrimidine inhibitor
6S9XX-ray2.60Covalent-allosteric inhibitor 15c
3O96X-ray2.70Allosteric inhibitor complex
3OCBX-ray2.70Pyrrolopyrimidine inhibitor
5KCVX-ray2.70ARQ 092 allosteric inhibitor
6HHHX-ray2.70Covalent-allosteric inhibitor 31
6HHIX-ray2.70Covalent-allosteric inhibitor 30b
4EKKX-ray2.80Akt1 with AMP-PNP
8ZPUX-ray2.80Anti-phosphopeptide antibody
6HHFX-ray2.90Covalent-allosteric inhibitor Borussertib
8JOWX-ray1.40Antibody with phosphopeptide
3QKLX-ray1.90Spirochromane inhibitors
Predicted Structures (AlphaFold)
AlphaFold IDSequence LengthGlobal pLDDTFraction Very High Confidence
P31749391983.620.54 (54%)

Section 5: Cross-Species Orthologs

SpeciesEnsembl Gene IDGene Symbol
Homo sapiens (Human)ENSG00000142208AKT1
Mus musculus (Mouse)ENSMUSG00000001729Akt1
Rattus norvegicus (Rat)ENSRNOG00000028629Akt1
Danio rerio (Zebrafish)ENSDARG00000099657akt1
Danio rerio (Zebrafish)ENSDARG00000111014(paralog)
Additional Model Organism Entrez IDs
SpeciesEntrez IDGene Symbol
Mouse11651Akt1
Rat24185Akt1
Drosophila41957Akt
Zebrafish100126861akt1

Section 6: Clinical Variants & AI Predictions ClinVar Variants Summary Total Variant Count: 943 Pathogenic Variants

ClinVar IDHGVS NotationTypeClassificationAssociated Condition
13983c.49G>A (p.Glu17Lys)SNVPathogenicProteus syndrome, Cowden syndrome 6
40162c.73C>T (p.Arg25Cys)SNVPathogenic
40163c.1303A>C (p.Thr435Pro)SNVPathogenic
800567c.49_50delinsAG (p.Glu17Arg)IndelPathogenic
Note: The E17K mutation is the most clinically significant, associated with Proteus syndrome and found in various cancers as a somatic driver mutation. Variants of Uncertain Significance (VUS) - Sample
ClinVar IDHGVS NotationClassification
1002469c.1088T>C (p.Met363Thr)Uncertain significance
1005578c.1097T>C (p.Ile366Thr)Uncertain significance
1006787c.1436C>T (p.Thr479Met)Uncertain significance
1009277c.16A>G (p.Ile6Val)Uncertain significance
1016933c.1277A>C (p.Lys426Thr)Uncertain significance
1018655c.1393C>T (p.Arg465Cys)Uncertain significance
1022066c.1260+1G>CUncertain significance
1035242c.349G>A (p.Glu117Lys)Uncertain significance
1035310c.749C>T (p.Ala250Val)Uncertain significance
1037529c.719C>G (p.Ser240Cys)Uncertain significance
AlphaMissense Predictions Total Predicted Variants: 3,188 Top 50 Predicted Pathogenic Missense Variants (am_class = likely_pathogenic):
VariantProtein ChangeAlphaMissense ScoreClassification
14:104770368:G:CF472L1.000likely_pathogenic
14:104770368:G:TF472L1.000likely_pathogenic
14:104770370:A:GF472L1.000likely_pathogenic
14:104770783:A:GF442S1.000likely_pathogenic
14:104770782:G:CF442L1.000likely_pathogenic
14:104770782:G:TF442L1.000likely_pathogenic
14:104770784:A:GF442L1.000likely_pathogenic
14:104770369:A:CF472C0.999likely_pathogenic
14:104770369:A:GF472S0.999likely_pathogenic
14:104770377:G:CF469L0.999likely_pathogenic
14:104770377:G:TF469L0.999likely_pathogenic
14:104770379:A:GF469L0.999likely_pathogenic
14:104770378:A:CF469C0.999likely_pathogenic
14:104770783:A:CF442C0.999likely_pathogenic
14:104770794:A:CF438L0.999likely_pathogenic
14:104770794:A:TF438L0.999likely_pathogenic
14:104770796:A:GF438L0.999likely_pathogenic
14:104770378:A:GF469S0.998likely_pathogenic
14:104770795:A:GF438S0.998likely_pathogenic
14:104770795:A:CF438C0.997likely_pathogenic
14:104770370:A:CF472V0.996likely_pathogenic
14:104770370:A:TF472I0.996likely_pathogenic
14:104770379:A:CF469V0.995likely_pathogenic
14:104770364:A:CY474D0.992likely_pathogenic
14:104770379:A:TF469I0.992likely_pathogenic
14:104770791:A:TD439E0.990likely_pathogenic
14:104770792:T:AD439V0.989likely_pathogenic
14:104770759:G:AT450I0.987likely_pathogenic
14:104770799:A:CY437D0.987likely_pathogenic
14:104770367:A:GS473P0.986likely_pathogenic
14:104770759:G:TT450K0.986likely_pathogenic
14:104770759:G:CT450R0.985likely_pathogenic
14:104770793:C:AD439Y0.982likely_pathogenic
14:104770793:C:GD439H0.982likely_pathogenic
14:104770364:A:TY474N0.977likely_pathogenic
14:104770792:T:CD439G0.976likely_pathogenic
14:104770366:G:AS473F0.975likely_pathogenic
14:104770756:G:TP451Q0.972likely_pathogenic
14:104770768:A:CI447S0.968likely_pathogenic
14:104770778:C:GA444P0.963likely_pathogenic
14:104770781:T:GT443P0.962likely_pathogenic
14:104770363:T:GY474S0.960likely_pathogenic
14:104770793:C:TD439N0.960likely_pathogenic
14:104770796:A:TF438I0.960likely_pathogenic
14:104770366:G:TS473Y0.959likely_pathogenic
14:104770757:G:AP451S0.959likely_pathogenic
14:104770757:G:TP451T0.957likely_pathogenic
14:104770768:A:GI447T0.956likely_pathogenic
14:104770780:G:TT443K0.955likely_pathogenic
14:104770768:A:TI447N0.954likely_pathogenic
SpliceAI Predictions Total Splice-Affecting Variants: 2,770 Top 50 Predicted Splice-Altering Variants:
VariantGeneEffectDelta Score
14:104770252:C:TAKT1acceptor_gain0.98
14:104770421:C:CCAKT1acceptor_gain0.96
14:104770253:G:TAKT1acceptor_gain0.96
14:104770252:C:CTAKT1acceptor_gain0.95
14:104770418:CAT:CAKT1acceptor_gain0.94
14:104770420:TC:TAKT1acceptor_loss0.92
14:104770421:C:AAKT1acceptor_loss0.92
14:104770422:T:GAKT1acceptor_loss0.92
14:104770423:G:CAKT1acceptor_loss0.91
14:104770419:AT:AAKT1acceptor_gain0.85
14:104770242:CAAA:CAKT1acceptor_gain0.85
14:104770427:G:CAKT1acceptor_loss0.86
14:104770417:TCAT:TAKT1acceptor_gain0.81
14:104770418:CATC:CAKT1acceptor_gain0.81
14:104770429:GTAGA:GAKT1acceptor_loss0.80
14:104770430:TAGAC:TAKT1acceptor_loss0.79
14:104770431:AGACA:AAKT1acceptor_loss0.79
14:104770432:GACAG:GAKT1acceptor_loss0.79
14:104770242:C:GAKT1acceptor_gain0.79
14:104770245:A:CAKT1acceptor_gain0.78
14:104770419:ATCT:AAKT1acceptor_gain0.78
14:104770424:TGGGT:TAKT1acceptor_loss0.76
14:104770425:GGGTG:GAKT1acceptor_loss0.76
14:104770251:C:CTAKT1acceptor_gain0.73
14:104770420:TCTG:TAKT1acceptor_gain0.72
14:104770245:A:GAKT1acceptor_gain0.72
14:104770240:T:TGAKT1acceptor_gain0.71

Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total Pathway Count: 42

Pathway IDPathway NameDisease Pathway
R-HSA-1257604PIP3 activates AKT signalingNo
R-HSA-165159MTOR signallingNo
R-HSA-198323AKT phosphorylates targets in the cytosolNo
R-HSA-198693AKT phosphorylates targets in the nucleusNo
R-HSA-199418Negative regulation of the PI3K/AKT networkNo
R-HSA-111447Activation of BAD and translocation to mitochondriaNo
R-HSA-203615eNOS activationNo
R-HSA-211163AKT-mediated inactivation of FOXO1ANo
R-HSA-354192Integrin signalingNo
R-HSA-389357CD28 dependent PI3K/Akt signalingNo
R-HSA-389513Co-inhibition by CTLA4No
R-HSA-392451G beta:gamma signalling through PI3KgammaNo
R-HSA-1358803Downregulation of ERBB2:ERBB3 signalingNo
R-HSA-1445148Translocation of SLC2A4 (GLUT4) to plasma membraneNo
R-HSA-1474151Tetrahydrobiopterin synthesis, recycling, salvageNo
R-HSA-3769402Deactivation of beta-catenin transactivating complexNo
R-HSA-450385BRF1 binds and destabilizes mRNANo
R-HSA-450604KSRP binds and destabilizes mRNANo
R-HSA-5218920VEGFR2 mediated vascular permeabilityNo
R-HSA-5628897TP53 Regulates Metabolic GenesNo
R-HSA-5674400Constitutive Signaling by AKT1 E17K in CancerYes
R-HSA-6785807Interleukin-4 and Interleukin-13 signalingNo
R-HSA-6804757Regulation of TP53 DegradationNo
R-HSA-6804758Regulation of TP53 Activity through AcetylationNo
R-HSA-6804759Regulation of TP53 Activity through Co-factorsNo
R-HSA-6811558PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingNo
R-HSA-69202Cyclin E associated events during G1/S transitionNo
R-HSA-69656Cyclin A:Cdk2-associated events at S phase entryNo
R-HSA-8849469PTK6 Regulates RTKs and Effectors AKT1/DOK1No
R-HSA-8876198RAB GEFs exchange GTP for GDP on RABsNo
R-HSA-8941332RUNX2 regulates genes in cell migrationNo
R-HSA-8948751Regulation of PTEN stability and activityNo
R-HSA-9009391Extra-nuclear estrogen signalingNo
R-HSA-9604323Negative regulation of NOTCH4 signalingNo
R-HSA-9607240FLT3 SignalingNo
R-HSA-9614399Regulation of localization of FOXO TFsNo
R-HSA-9634638Estrogen-dependent nuclear events downstream of ESRNo
R-HSA-9755511KEAP1-NFE2L2 pathwayNo
R-HSA-9755779SARS-CoV-2 targets host intracellular signallingYes
R-HSA-9841251Mitochondrial unfolded protein responseNo
R-HSA-9856530Laminar flow shear stress activates PIEZO1/PECAM1/KDRNo
R-HSA-9856532Mechanical load activates PIEZO1 and integrinsNo
Gene Ontology Annotations Total GO Term Count: 171 Biological Process (TOP 20 of ~120)
GO IDTerm Name
GO:0043491phosphatidylinositol 3-kinase/protein kinase B signal transduction
GO:0006468protein phosphorylation
GO:0046777protein autophosphorylation
GO:0007165signal transduction
GO:0035556intracellular signal transduction
GO:0008286insulin receptor signaling pathway
GO:0048009insulin-like growth factor receptor signaling pathway
GO:0007173epidermal growth factor receptor signaling pathway
GO:0043066negative regulation of apoptotic process
GO:0042981regulation of apoptotic process
GO:0006006glucose metabolic process
GO:0042593glucose homeostasis
GO:0005978glycogen biosynthetic process
GO:0045725positive regulation of glycogen biosynthetic process
GO:0031929TOR signaling
GO:0010507negative regulation of autophagy
GO:0008283cell population proliferation
GO:0030307positive regulation of cell growth
GO:0030335positive regulation of cell migration
GO:0006809nitric oxide biosynthetic process
Molecular Function (TOP 20 of ~25)
GO IDTerm Name
GO:0004674protein serine/threonine kinase activity
GO:0004672protein kinase activity
GO:0004712protein serine/threonine/tyrosine kinase activity
GO:0106310protein serine kinase activity
GO:0016301kinase activity
GO:0005524ATP binding
GO:0005547phosphatidylinositol-3,4,5-trisphosphate binding
GO:0043325phosphatidylinositol-3,4-bisphosphate binding
GO:0019899enzyme binding
GO:0019900kinase binding
GO:0019901protein kinase binding
GO:0042802identical protein binding
GO:0042803protein homodimerization activity
GO:0005516calmodulin binding
GO:007188914-3-3 protein binding
GO:0030235nitric-oxide synthase regulator activity
GO:0030291protein serine/threonine kinase inhibitor activity
GO:0099104potassium channel activator activity
GO:1904841TORC2 complex binding
Cellular Component (TOP 20 of ~26)
GO IDTerm Name
GO:0005829cytosol
GO:0005737cytoplasm
GO:0005634nucleus
GO:0005654nucleoplasm
GO:0005886plasma membrane
GO:0016020membrane
GO:0005739mitochondrion
GO:0005758mitochondrial intermembrane space
GO:0030027lamellipodium
GO:0005938cell cortex
GO:0005819spindle
GO:0015630microtubule cytoskeleton
GO:0005911cell-cell junction
GO:0005929cilium
GO:0036064ciliary basal body
GO:0031982vesicle
GO:0032991protein-containing complex
GO:0033011perinuclear theca
GO:0098978glutamatergic synapse
GO:0098794postsynapse

Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions Total Interaction Count: 14,324 TOP 50 Highest-Confidence Interacting Proteins:

Interacting ProteinUniProtScoreDescription
CDC42P21181999Cell division control protein 42
AKT1 (self)P31749999Homodimerization
HSP90AA1P07900996Heat shock protein 90 alpha
HSP90AB1P08238996Heat shock protein 90 beta
PHLPP1O60346995PH domain leucine-rich repeat phosphatase 1
CYBAP04839994Cytochrome b-245 alpha chain
NCF2P19878993Neutrophil cytosol factor 2
ARRB2P32121993Beta-arrestin-2
CYBBP13498992Cytochrome b-245 beta chain
ERO1AQ15080992ERO1-like protein alpha
SERPINA6P19957991Corticosteroid-binding globulin
SMAD3P84022990Mothers against decapentaplegic homolog 3
NISCHQ8IY63986Nischarin
AREGP15498985Amphiregulin
ARHGDIAP52565982Rho GDP-dissociation inhibitor 1
PAK1Q13153981Serine/threonine-protein kinase PAK 1
MDM2Q00987980E3 ubiquitin-protein ligase Mdm2
SRCP12931977Proto-oncogene tyrosine-protein kinase Src
NUP98P42768973Nuclear pore complex protein Nup98-Nup96
PTENP60484968Phosphatase and tensin homolog
INSRP14598993Insulin receptor
PIK3CAP42336951PI3K catalytic subunit alpha
PIK3CGP48736948PI3K catalytic subunit gamma
MTORP42345955Mechanistic target of rapamycin
INSP01308953Insulin
IRS1P35568942Insulin receptor substrate 1
FOXO1Q12778941Forkhead box protein O1
TP53P04637935Cellular tumor antigen p53
EGFP01133934Epidermal growth factor
BCL2P10415934Apoptosis regulator Bcl-2
IQGAP1P46940966IQ motif containing GTPase activating 1
GSK3BP49841964Glycogen synthase kinase-3 beta
STAT3P40763926Signal transducer and activator of transcription 3
CTNNB1P35222930Catenin beta-1
PDPK1O155309273-phosphoinositide-dependent protein kinase 1
FOXO3O43524929Forkhead box protein O3
RICTORQ6R327926Rapamycin-insensitive companion of mTOR
TCL1AP49840830+T-cell leukemia/lymphoma protein 1A
BADQ92934934BCL2-associated agonist of cell death
TSC2P49815949Tuberin
CDKN1AP38936921Cyclin-dependent kinase inhibitor 1
IntAct Curated Interactions Total IntAct Interactions: 934 Notable Physical Interactions:
InteractionPartnerTypeConfidence
EBI-15704518GSK3Bdirect interaction0.830
EBI-12698333TCL1Aphysical association0.830
EBI-16167771PDPK1phosphorylation reaction0.820
EBI-16098061MTORphosphorylation reaction0.810
EBI-16167795PPP2CAdephosphorylation reaction0.760
EBI-15098378FOXO3physical association0.750
EBI-15790008THEM4physical association0.730
EBI-1554707SETDB1physical association0.720
EBI-15749834ARRB2physical association0.700
EBI-21864297AKT2physical association0.640
EBI-21228493TTC3physical association0.640
EBI-15710512ALYREFdirect interaction0.640
EBI-15898138DNMT1direct interaction0.610
EBI-15728240FOXO1direct interaction0.570
EBI-1214863MAP3K5phosphorylation reaction0.560
EBI-15687774STUB1physical association0.560
ESM2 Structural Similarity Total Similar Proteins: 51 TOP 20 Structurally Similar Proteins (by embedding):
UniProt IDSimilarity CountTop SimilarityAvg Similarity
P31748500.99780.9663
P31751500.99980.9678
P31750500.99990.9651
Q9Y243500.99980.9684
Q9WUA6500.99980.9685
Q60823500.99980.9680
Q63484500.99980.9685
Q01314500.99970.9653
P47196500.99990.9648
P47197500.99950.9693
P34947500.99950.9651
Q7ZX15500.99940.9689
Q6IP76500.99940.9700
Q16644500.99900.9578
Q3SYZ2500.99900.9582
Q3UMW7500.99850.9625
P12368500.99640.9446
P13861500.99830.9435
P00515500.99830.9424
Q75H77500.99770.9666
DIAMOND Sequence Homology Total Homologous Proteins: 281 TOP 20 Sequence Similar Proteins:
UniProt IDTop Identity (%)BitScore
P31748 (AKT2)100.00977
P31750 (AKT3)100.00979
P32023100.001071
O0896799.80798
P2344399.701055
F1M7Y599.701222
P0051799.70709
P0512999.401446
P0538399.40709
P0513199.40708
P1761299.40706
P0577299.401382
P0921699.101495
P1725299.301398
P0569699.301399
O0014199.30863
P2532199.10705
P1605499.101498
P1010299.301399
O7558299.301525

Section 9: Transcription Factor Regulatory Data Note: AKT1 is primarily a kinase, not a transcription factor. However, it regulates gene expression through phosphorylation of transcription factors. Downstream Targets (Genes Regulated BY AKT1 Phosphorylation) Total CollecTRI Entries: 85 (5 as TF, 80 as target) AKT1 Acts as Regulator of:

Target GeneRegulation TypeMechanism
CDKN1B (p27)RepressionPhosphorylation leads to cytoplasmic retention/degradation
SLC2A1 (GLUT1)ActivationPromotes glucose transporter expression
STUB1Activation
FSTL1Activation
MIA3Activation
Upstream Regulators (TFs that Regulate AKT1 Gene) Total: 80 transcription factors
TF GeneRegulationConfidence
CTNNB1 (β-catenin)ActivationHigh
TCF7L2ActivationHigh
ARActivationLow
RUNX2Activation-
ITGAXActivation-
TP53RepressionLow
RELA (NF-κB p65)RepressionLow
NFKB1Repression-
NFKBRepressionLow
IRF1Repression-
CTCFRepression-
APCRepression-
ARID4BRepression-
POU5F1 (Oct4)RepressionLow
CREB1UnknownLow
ESR1UnknownLow
GLI1UnknownLow
RUNX3UnknownLow
STAT3UnknownLow
DNA Binding (JASPAR) AKT1 is not a DNA-binding transcription factor - it exerts regulatory effects through phosphorylation of downstream effectors including FOXO1, FOXO3, GSK3B, and BAD.

Section 10: Drug & Pharmacology Data ChEMBL Targeting Molecules Total Molecules Targeting AKT1: 6,498+ (via CHEMBL4282) Drugs by Development Phase (Phase 2+) Total Count: 23

ChEMBL IDDrug NameTypePhaseNotes
CHEMBL2325741CAPIVASERTIBSmall molecule4 (Approved)Selective AKT inhibitor
CHEMBL125MILTEFOSINESmall molecule4 (Approved)Alkylphosphocholine
CHEMBL1448NICLOSAMIDESmall molecule4 (Approved)Antihelminthic
CHEMBL608533MIDOSTAURINSmall molecule4 (Approved)Multi-kinase inhibitor
CHEMBL2177390IPATASERTIBSmall molecule3Pan-AKT inhibitor
CHEMBL2219422AFURESERTIBSmall molecule3Pan-AKT inhibitor
CHEMBL603469LESTAURTINIBSmall molecule3Multi-kinase inhibitor
CHEMBL223360LINIFANIBSmall molecule3VEGFR/PDGFR inhibitor
CHEMBL38380FASUDILSmall molecule3Rho-kinase inhibitor
CHEMBL50QUERCETINSmall molecule3Natural flavonoid
CHEMBL372764PERIFOSINESmall molecule3Alkylphospholipid
CHEMBL1079175MK-2206Small molecule2Allosteric AKT inhibitor
CHEMBL1234354PF-04691502Small molecule2PI3K/mTOR inhibitor
CHEMBL3137336UPROSERTIBSmall molecule2AKT inhibitor
CHEMBL521851PICTILISIBSmall molecule2PI3K inhibitor
CHEMBL4297188MIRANSERTIBSmall molecule2AKT inhibitor
CHEMBL4871106RUPITASERTIBSmall molecule2AKT inhibitor
CHEMBL565612SOTRASTAURINSmall molecule2PKC inhibitor
CHEMBL28509EDELFOSINESmall molecule2Alkylphospholipid
CHEMBL1355299SULFAETHIDOLESmall molecule2
CHEMBL1908343KALAFUNGINSmall molecule2
CHEMBL1980715LAUROGUADINESmall molecule2
CHEMBL6246ELLAGIC ACIDSmall molecule2Natural polyphenol
ChEMBL Target Entries for AKT1
Target IDTypeDescription
CHEMBL4282SINGLE PROTEINRAC-alpha serine/threonine-protein kinase
CHEMBL2111353PROTEIN FAMILYSerine/threonine-protein kinase AKT
CHEMBL3885629PROTEIN FAMILYAKT1/Ribosomal protein S6 kinase beta-1
CHEMBL4106175PROTEIN FAMILYSerine/threonine-protein kinase Rac alpha/beta
CHEMBL3038463PROTEIN COMPLEXAKT/p21CIP1
CHEMBL4523748PROTEIN-PROTEIN INTERACTIONAKT1/PPP1CA
CHEMBL5169068PROTEIN-PROTEIN INTERACTIONVHL/AKT1
CHEMBL5169081PROTEIN-PROTEIN INTERACTIONCRBN/AKT1
PharmGKB Status
AttributeValue
PharmGKB IDPA24684
VIP GeneYes (Very Important Pharmacogene)
Has Variant AnnotationYes
CPIC GuidelineNo

Section 11: Expression Profiles Bgee Expression Summary

AttributeValue
Expression BreadthUbiquitous
Total Present Calls273
Total Absent Calls18
Total Conditions Tested291
Max Expression Score98.05
Average Expression Score87.37
Gold Quality Calls241
TOP 30 Tissues by Expression Score
RankTissue/Cell TypeExpression ScoreQuality
1Stromal cell of endometrium98.05Gold
2Ganglionic eminence97.94Gold
3Endometrium epithelium97.88Gold
4Left adrenal gland97.72Gold
5Left adrenal gland cortex97.72Gold
6Right adrenal gland97.54Gold
7Lower esophagus muscularis layer97.52Gold
8Lower esophagus97.50Gold
9Right adrenal gland cortex97.44Gold
10Ventricular zone (brain)97.42Gold
11Cortical plate (brain)97.28Gold
12Right coronary artery97.16Gold
13Gall bladder97.10Gold
14Esophagogastric junction muscularis97.06Gold
15Body of stomach97.02Gold
16Muscle layer of sigmoid colon97.00Gold
17Ascending aorta96.99Gold
18Thoracic aorta96.99Gold
19Popliteal artery96.92Gold
20Tibial artery96.91Gold
21Aorta96.88Gold
22Adrenal cortex96.78Gold
23Adrenal gland96.76Gold
24Descending thoracic aorta96.76Gold
25Upper lobe of left lung96.68Gold
26Apex of heart96.67Gold
27Right lung96.58Gold
28Granulocyte96.48Gold
29Left coronary artery96.48Gold
30Right lobe of thyroid gland96.25Gold
Expression Pattern Summary AKT1 shows ubiquitous expression across virtually all human tissues and cell types, consistent with its fundamental role in cell survival, growth, and metabolism. The highest expression levels are observed in:
  • Reproductive tissues: Endometrium, stromal cells
  • Endocrine tissues: Adrenal glands, thyroid
  • Cardiovascular system: Aorta, coronary arteries, peripheral arteries
  • Nervous system: Brain developmental zones (ganglionic eminence, cortical plate)
  • Gastrointestinal tract: Esophagus, stomach, colon

Section 12: Disease Associations Mendelian/Monogenic Disease Links (GenCC)

DiseaseOMIM/Orphanet IDClassificationInheritanceEvidence
Proteus syndromeOMIM:176920DefinitiveAutosomal dominant (somatic mosaic)G2P
Proteus syndromeOMIM:176920StrongAutosomal dominantLabcorp
Cowden syndrome 6OMIM:615109LimitedUnknownLabcorp
Cowden diseaseORPHANET:201SupportiveAutosomal dominantOrphanet
Orphanet Disease Associations
Orphanet IDDisease NameTypeGene CountPhenotype Count
744Proteus syndromeMalformation syndrome1115
201Cowden syndromeClinical subtype957
2495MeningiomaDisease1274
OMIM Associations
MIM NumberTypeDescription
164730GeneAKT1 gene
176920PhenotypeProteus syndrome
615109PhenotypeCowden syndrome 6
HPO Phenotype Associations Total Associated Phenotypes: 256 TOP 50 Clinical Phenotypes:
HPO IDPhenotype Term
HP:0000006Autosomal dominant inheritance
HP:0001442Typified by somatic mosaicism
HP:0001548Overgrowth
HP:0001528Hemihypertrophy
HP:0000256Macrocephaly
HP:0001519Disproportionate tall stature
HP:0001513Obesity
HP:0000158Macroglossia
HP:0001012Multiple lipomas
HP:0001028Hemangioma
HP:0001048Cavernous hemangioma
HP:0001004Lymphedema
HP:0000962Hyperkeratosis
GP:0000982Palmoplantar keratoderma
HP:0001072Thickened skin
HP:0000324Facial asymmetry
HP:0001067Neurofibroma
HP:0001249Intellectual disability
HP:0001263Global developmental delay
HP:0001250Seizure
HP:0000717Autism
HP:0002282Gray matter heterotopia
HP:0000238Hydrocephalus
HP:0001363Craniosynostosis
HP:0001317Abnormal cerebellum morphology
HP:0000501Glaucoma
HP:0000545Myopia
HP:0000520Proptosis
HP:0000365Hearing impairment
HP:0000767Pectus excavatum
HP:0001555Asymmetry of the thorax
HP:0000077Abnormality of the kidney
HP:0000105Enlarged kidney
HP:0000107Renal cyst
HP:0000820Abnormality of the thyroid gland
HP:0000853Goiter
HP:0000044Hypogonadotropic hypogonadism
HP:0000053Macroorchidism
HP:0000771Gynecomastia
HP:0001744Splenomegaly
HP:0002204Pulmonary embolism
HP:0001645Sudden cardiac death
HP:0001342Cerebral hemorrhage
HP:0002017Nausea and vomiting
HP:0000276Long face
HP:0000268Dolichocephaly
HP:0000316Hypertelorism
HP:0000369Low-set ears
HP:0000400Macrotia
HP:0001156Brachydactyly
GWAS Associations Total GWAS Count: 10
Study IDTraitMapped GeneP-value
GCST010241Apolipoprotein A1 levelsAKT15.0e-57
GCST010242HDL cholesterol levelsAKT14.0e-38
GCST006611HDL cholesterolAKT13.0e-26
GCST003524Endometrial cancerAKT14.0e-08
GCST003525Endometrial endometrioid carcinomaAKT14.0e-08
GCST002899HDL cholesterolZBTB42-VESTAR8.0e-09
GCST002223HDL cholesterolZBTB42-VESTAR1.0e-08
GCST004232HDL cholesterol levelsZBTB42-VESTAR3.0e-08
GCST011816Vitamin C levelsAKT11.0e-08
GCST90002398Neutrophil countAKT17.0e-09
Cancer Associations AKT1 mutations are found in multiple cancer types (somatic):
  • Breast cancer (E17K hotspot)
  • Colorectal cancer
  • Ovarian cancer
  • Endometrial cancer
  • Meningioma
  • Various solid tumors The E17K mutation in the PH domain causes constitutive membrane localization and activation, driving oncogenic signaling.

SUMMARY STATISTICS

CategoryCount
Gene Identifiers5+ databases
Ensembl Transcripts90
RefSeq Transcripts (Human)7 reviewed
UniProt Entries8 (1 reviewed canonical)
Protein Length480 aa
InterPro Domains10
PDB Structures42
Orthologs (Major)4 species
ClinVar Variants943
Pathogenic Variants4
AlphaMissense Predictions3,188
SpliceAI Predictions2,770
Reactome Pathways42
GO Terms171
STRING Interactions14,324
IntAct Interactions934
Targeting Drugs (Phase 2+)23
Approved Drugs4
Expression TissuesUbiquitous (273/291 conditions)
HPO Phenotypes256
GWAS Associations10
Mendelian Diseases2-3

This reference document was generated from biobtree database queries aggregating data from HGNC, Ensembl, NCBI Entrez, UniProt, PDB, AlphaFold, ClinVar, AlphaMissense, SpliceAI, Reactome, Gene Ontology, STRING, IntAct, ChEMBL, PharmGKB, Bgee, GenCC, Orphanet, HPO, and GWAS Catalog.